Insider Sale by Gagnon Robert E. (Chief Financial Officer)
Trade Summary
1 week ago, Gagnon Robert E., serving as Chief Financial Officer at Opus Genetics, Inc. (IRD), sold 28,000 shares at $4.54 per share, for a total transaction value of $127,212.40. Following this transaction, Gagnon Robert E. now holds 556,375 shares of IRD.
This sale represents a 4.79% decrease in Gagnon Robert E.'s stake in the company. This is considered a medium-conviction trade.
The trade was executed on Thursday, September 3, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, September 8, 2026 at 4:05 PM ET, 5 days after the trade was made.
Opus Genetics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.
Trade Price
$4.54
Quantity
28,000
Total Value
$127,212.40
Shares Owned
556,375
Trade Date
7 days ago
SEC Filing Date
at 4:05 PM ET
Filed 5 days after trade
Discussion